Abstract

Reading the Immune System for Rapid Diagnosis of Acute Infection and Sepsis

David Rawling, Senior Principal Scientist, Inflammatix, Inc.

Inflammatix is changing how physicians diagnose and treat acute infections and sepsis by leveraging state-of-the-art bioinformatics, assay chemistry and an exclusive, patent-pending biomarker set.?Our initial focus is on development of host response-based diagnostic tests for detecting acute infections and sepsis.